Disclosures for "A Case of Adult-onset MELAS as a Rapidly Progressive Dementia: Variant of Unknown Significance and the Importance of Neuropathologic Confirmation"
-
Dr. Wiggins has nothing to disclose.
-
Dr. Jain has nothing to disclose.
-
The institution of Dr. Tate has received research support from Ipsen. The institution of Dr. Tate has received research support from Boston Scientific. The institution of Dr. Tate has received research support from Revance Therapeutics. The institution of Dr. Tate has received research support from CHDI Foundation. The institution of Dr. Tate has received research support from NINDS. The institution of Dr. Tate has received research support from Michael J. Fox Foundation.
-
Dr. Kirby has nothing to disclose.
-
Dr. Dickson has nothing to disclose.
-
Dr. Bateman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. Bateman has received research support from NIA. The institution of Dr. Bateman has received research support from Dementia Alliance of North Carolina. The institution of Dr. Bateman has received research support from Alzheimer's Association. The institution of Dr. Bateman has received research support from Alzheimer's Drug Discovery Foundation. Dr. Bateman has a non-compensated relationship as a Committee Member with UCNS that is relevant to AAN interests or activities.